Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sutent price (correction)

Executive Summary

Based on the wholesale acquisition cost of Sutent (sunitinib), which is $6,412.50 for a 30 count bottle of 50 mg capsules, the product's average monthly cost is $4,275. This prices Sutent at a slight discount to Bayer/Onyx' Nexavar (sorafenib) which carries a WAC of $4,333 for a one-month supply. In a previous story on the approval of Sutent, "The Pink Sheet" incorrectly identified the price of the product and incorrectly referred to the average wholesale price of Nexavar as the price to patients (1"The Pink Sheet" Jan. 30, 2006, p. 4)...

You may also be interested in...



Pfizer Oncologic Sutent Will Have Dosing, Slight Price Advantage Over Nexavar

Pfizer's newly approved oncologic Sutent will have a dosing advantage and will be priced at a slight discount compared to Bayer/Onyx' Nexavar

Sanofi Paid $14.6bn In Rebates In 2020; Net Prices Were Down

The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.

Can Vir/GSK’s COVID-19 Antibody Prove Its Worth In Early Disease?

Other antibody treatments have shown efficacy in early-stage disease after faltering in hospitalized patients.

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel